KUALA LUMPUR, Nov 18 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation, has been selected by three biopharma developers, including the Institute of Science Tokyo, to provide cell therapy services at its Yokohama facility.